RxDoctor Payments Data

Joseph Soufer

Internal Medicine · Waterbury, CTNPI 1699797290

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,385 of the $2,135 with a category attached, or 64.9%. Eli Lilly accounts for 83.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,791 and has fallen 98.0% since, to $35 in 2025.

$2,135in general payments, 2019–2025

Across 40 payments — averaging $53.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Novo Nordisk$309
  • Merck$35
$21,826,679in research payments, 2019–2025

Across 4,851 payments — averaging $4499.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9.5M
  • Modernatx, Inc.$3.7M
  • Senseonics, Incorporated$1.1M
  • Novo Nordisk AS$1M
  • AstraZeneca$700K
  • Amgen$666K
  • plus $5.1M from 34 others

What the payments were for

  • Travel & lodging$1,38565%
  • Food & beverage$45922%
  • Education$29014%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly29$1,791
Novo Nordisk10$309
Merck1$35

How this compares

$2,135 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut

Other internal medicine in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →